kaksi kirjainta, joilla yksilöidään viejämaa seuraavasti: UA,
It must be confirmed that further scientific knowledge in the available literature on the additive has not changed the original assessment on efficacy since the authorisation for putting into circulation of the original additiveEurLex-2 EurLex-2
kaksi kirjainta viejämaan yksilöimiseksi seuraavasti: UA= Ukraina
In clinical trials, the incidence of parkinsonism and dystonia in olanzapine-treated patients was numerically higher, but not statistically significantly different from placeboEurLex-2 EurLex-2
• UA/NSTEMIn ja STEMIn hoito-Fondaparinuuksia ei pidä käyttää potilailla, joilla kreatiniinipuhdistuma on < # ml/min (ks. kohta
It is therefore necessary to fix an indicative allocation of the available amount between the Member States concerned in accordance with Article # of Regulation (EC) NoEMEA0.3 EMEA0.3